Literature DB >> 1921239

[Thrombocyte transfusion: clinical aspects, follow-up and complications].

D Söhngen1, W Schneider.   

Abstract

Thrombocytopenia is the most common cause of bleeding tendency, and, if due to impaired platelet production, is best treated by platelet transfusions. Prophylactic transfusions for asymptomatic patients should be considered if platelet count is below 20,000/microliters. However, if bleeding occurs or surgery is inevitable, platelet count should be maintained above 50,000/microliters. The benefit of platelet transfusions has to be balanced against risks like fever, infections and haemolysis. The effectiveness of platelet transfusions should be examined after 1 and 24 hrs by measuring the corrected count increment (CCI). Not only alloimmunization is a reason for unsatisfactory platelet increments. A poor CCI can also be due to fever, sepsis, hepato-splenomegaly or special drugs, which must be taken into account when assessing the demand for platelet transfusions.

Entities:  

Mesh:

Year:  1991        PMID: 1921239      PMCID: PMC7095859          DOI: 10.1007/bf01647409

Source DB:  PubMed          Journal:  Klin Wochenschr        ISSN: 0023-2173


  46 in total

1.  ABO incompatibility and platelet transfusion.

Authors: 
Journal:  Lancet       Date:  1990-01-20       Impact factor: 79.321

2.  [Thrombocyte storage as platelet-rich plasmas or as concentrate?].

Authors:  D Söhngen; A Schröter; A Saure; V Kretschmer; H Falke; H Prinz
Journal:  Beitr Infusionsther       Date:  1988

3.  Post-transfusion purpura.

Authors:  C Mueller-Eckhardt
Journal:  Br J Haematol       Date:  1986-11       Impact factor: 6.998

4.  The prophylactic treatment of thrombocytopenic leukemic patients with platelets: a double blind study.

Authors:  D J Higby; E Cohen; J F Holland; L Sinks
Journal:  Transfusion       Date:  1974 Sep-Oct       Impact factor: 3.157

5.  The bleeding time as a screening test for evaluation of platelet function.

Authors:  L A Harker; S J Slichter
Journal:  N Engl J Med       Date:  1972-07-27       Impact factor: 91.245

6.  [The Tübingen concept of transfusion medical care in bone marrow transplants].

Authors:  D Wernet; M Schnaidt; G Mayer; W Schneider
Journal:  Beitr Infusionther Klin Ernahr       Date:  1987

Review 7.  [HIV infection and blood donation services].

Authors:  B Gathof; J Eberle; U Bäcker; F Deinhardt; A G Gathof
Journal:  Internist (Berl)       Date:  1988-02       Impact factor: 0.743

8.  Buffy coat or platelet-rich plasma? Comparison of two platelet-processing techniques.

Authors:  Z Rácz; M Thék
Journal:  Vox Sang       Date:  1984       Impact factor: 2.144

Review 9.  Controversies in platelet transfusion therapy.

Authors:  S J Slichter
Journal:  Annu Rev Med       Date:  1980       Impact factor: 13.739

10.  Hemotherapy in patients undergoing blood group incompatible bone marrow transplantation.

Authors:  L C Lasky; P I Warkentin; J H Kersey; N K Ramsay; P B McGlave; J McCullough
Journal:  Transfusion       Date:  1983 Jul-Aug       Impact factor: 3.157

View more
  1 in total

1.  [Conventional vs pathogen-inactivated platelet concentrates for the treatment of perioperative coagulopathy. A prospective cohort study].

Authors:  C F Weber; D Meininger; C Byhahn; E Seifried; K Zacharowski; E Adam; R Henschler; M M Müller
Journal:  Chirurg       Date:  2011-04       Impact factor: 0.955

  1 in total

北京卡尤迪生物科技股份有限公司 © 2022-2023.